x
Mail icon Ready to start sponsoring events? Join and view unlimited sponsorship proposals for FREE!
Cycling
The Tour of California (Amgen Tour of California) is an annual professional cycling stage race on the UCI America Tour and USA Cycling Professional Tour. It began on February 19, 2006. The eight-day race covers 650–700 miles (1,045 - 1,126 km) through California. A typical edition might begin in Nevada City, travel through the redwoods, wine country and the Pacific Coast, and finish in a southern California city such as Escondido. The 2009 race crossed the Central Valley from Merced to Fresno, with an excursion through the Sierra Nevada foothills, before crossing to the coast. The tour is sponsored by Amgen, a large California-based biotech company. read more
The Tour of California (Amgen Tour of California) is an annual professional cycling stage race on the UCI America Tour and USA Cycling Professional Tour. It began on February 19, 2006. The eight-day race covers 650–700 miles (1,045 - 1,126 km) through California. A typical edition might begin in Nevada City, travel through the redwoods, wine country and the Pacific Coast, and finish in a southern California city such as Escondido. The 2009 race crossed the Central Valley from Merced to Fresno, with an excursion through the Sierra Nevada foothills, before crossing to the coast. The tour is sponsored by Amgen, a large California-based biotech company. read more
Activity
Activity
Deals
Locations
Similar Properties
Agencies
Jobs
Proposals
Analytics
This SponsorPitch page is about Amgen Tour of California and contains information about this organization's sponsorship activity, sponsorship decision makers and sponsorship preferences. This page is not endorsed by or affiliated with Amgen Tour of California, though it may be actively managed and updated by company representatives. If you currently work at this organization, click the Do you work here button to request management privileges. All trademarks, service marks and copyrights are property of their respective owners.